Guus Rimmelzwaan

20PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingTumour immunologyFoetal development and medicineMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 27, 2026
Roles of the Chemokine Receptor CX3CR1 in the Pathogenesis of RSV Infections.

|Aug 12, 2024
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity.

Amare Aregay, Jan Slunečko, Petra Bogovic

|Aug 07, 2024
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins.

Amare Aregay, Jan Slunečko, Miša Korva

|Jul 18, 2024
The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms.

Lucas Wilken, Guus F Rimmelzwaan, Husni Elbahesh

|Jul 01, 2024
Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice.

Chittappen K Prajeeth, Isabel Zdora, Giulietta Saletti

|Jan 26, 2024
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.

Mareike Kubinski, Jana Beicht, Thomas Gerlach

Pageof 4

Frequent Collaborators

7 joint publications

Albert D M E Osterhaus

7 joint publications

Chittappen Kandiyil Prajeeth

5 joint publications

Lucas Wilken

3 joint publications

Robert Meineke